Security key
413197104
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 55,552,492
- Share change
- +5,358,407
- Total reported value
- $1,556,328,190
- Put/Call ratio
- 242%
- Price per share
- $28.01
- Number of holders
- 308
- Value change
- +$125,878,517
- Number of buys
- 166
- Number of sells
- 146
Report period
Q1 2026
Institutions
308
Top holders
10
HRMY full security history
Previous quarter: Q4 2025
Harmony Biosciences Holdings, Inc. SEC filings
Harmony Biosciences Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 413197104
Recent filing periods:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Marshman Fund Trust II |
3/4/5
13D/G
|
10%+ Owner |
11%
from 13D/G
|
6,051,120
|
$183,364,064 | — | 01 Nov 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
7,088,688
|
$265,258,704 | — | 31 Dec 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
5.4%
|
3,112,812
|
$116,481,431 | -$27,472,267 | 31 Dec 2025 | |
| Valor IV Pharma Holdings, LLC |
3/4/5
|
10%+ Owner |
0.04%
|
23,714
|
$834,732 | — | 28 Aug 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
4,813,357
|
$180,115,819 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
3.2%
|
1,841,672
|
$68,915,366 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.2%
|
1,830,726
|
$68,506,807 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
1,661,850
|
$62,186,427 | — | 31 Dec 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
2.9%
|
1,657,093
|
$62,008,000 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
2.6%
|
1,491,605
|
$55,815,859 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,270,586
|
$47,551,305 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.9%
|
1,070,471
|
$40,057,025 | — | 31 Dec 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
1.7%
|
961,667
|
$35,986,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
817,507
|
$30,591,142 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
813,889
|
$30,455,726 | — | 31 Dec 2025 | |
| Boston Partners |
13F
|
Company |
1.2%
|
708,943
|
$26,367,837 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.99%
|
569,362
|
$21,305,526 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.94%
|
541,281
|
$20,254,735 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.91%
|
525,145
|
$19,650,926 | — | 31 Dec 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.88%
|
510,024
|
$19,085,098 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.87%
|
500,000
|
$18,710,000 | — | 31 Dec 2025 | |
| venBio Partners LLC |
13F
|
Company |
0.85%
|
489,194
|
$18,305,639 | — | 31 Dec 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.8%
|
459,134
|
$17,180,794 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.78%
|
450,805
|
$16,869,123 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.73%
|
420,410
|
$15,731,743 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
418,938
|
$15,676,660 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
417,955
|
$15,639,876 | — | 31 Dec 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.72%
|
415,000
|
$15,529,300 | — | 31 Dec 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.62%
|
359,818
|
$13,464,000 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.6%
|
344,171
|
$12,878,879 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.56%
|
322,295
|
$12,059,951 | — | 31 Dec 2025 | |
| Man Group plc |
13F
|
Company |
0.53%
|
306,743
|
$11,478,324 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.52%
|
299,404
|
$11,203,698 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.52%
|
297,228
|
$11,122,271 | — | 31 Dec 2025 | |
| Tieton Capital Management, LLC |
13F
|
Company |
0.52%
|
297,081
|
$11,117,000 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.5%
|
290,353
|
$10,865,009 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
290,292
|
$10,862,727 | — | 31 Dec 2025 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
0.49%
|
281,721
|
$10,542,000 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.48%
|
278,188
|
$10,409,795 | — | 31 Dec 2025 | |
| CX Institutional |
13F
|
Company |
0.48%
|
275,809
|
$10,321,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
275,058
|
$10,292,670 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.47%
|
272,572
|
$10,199,644 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.46%
|
264,417
|
$9,894,499 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.46%
|
263,843
|
$9,873,005 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.44%
|
252,575
|
$9,451,356 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.43%
|
249,124
|
$9,322,220 | — | 31 Dec 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.43%
|
248,107
|
$9,284,164 | — | 31 Dec 2025 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.41%
|
237,103
|
$8,872,394 | — | 31 Dec 2025 | |
| Universal- Beteiligungs- und Servicegesellschaft mbH |
13F
|
Individual |
0.41%
|
234,895
|
$8,794,419 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
231,696
|
$8,670,064 | — | 31 Dec 2025 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q1 2026
As of 31 Mar 2026,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,552,492 shares.
The largest 10 holders included
BlackRock, Inc., FMR LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, AMERICAN CENTURY COMPANIES INC, VANGUARD CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, LSV ASSET MANAGEMENT, SG Americas Securities, LLC, STATE STREET CORP, and ARMISTICE CAPITAL, LLC.
This page lists
308
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
323
Q1 2026 holders
308
Holder diff
-15
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.